Benitez, Sal-beng .
HRN: 00-57-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
CEFUROXIME 500MG (TAB)
09/24/2025
10/01/2025
ORAL
500 Mg
BID
S/P NSVD With RMLE
Checking Initial Appropriateness
09/25/2025
CEFUROXIME 1.5GM (VIAL)
09/25/2025
09/26/2025
IV
1.5gms
Q8hrs X 3 Doses
UTI
Checking Initial Appropriateness